# Nureca Ltd (NURECA)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹271.8
Day Change: -0.31%
52W High: ₹343.6
52W Low: ₹200.1
Market Cap: ₹259 Cr

## Valuation
P/E: 24.57
P/B: 1.57
EPS: ₹11.03
Book Value: ₹172.08
Dividend Yield: 0%

## Returns
1Y Return: -1.3%

## Profitability
ROE: 0%
ROCE: -9.97%
Debt/Equity: 0.03
Revenue Growth: 49.8%
Profit Growth: 0%
EBITDA Margin: 4.19%
Operating Margin: 6.94%

## About
Nureca Ltd is a Medical Devices company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Medical Devices
Sub Industry: Unknown

## Business Model
Overview: Nureca Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Devices. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement: Closure of Trading Window
- BSE Filing: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-18T22:59:33.706Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:33.706Z
Quant Updated: 2026-05-18T22:59:33.706Z
Sentiment Updated: 2026-05-18T22:59:33.706Z
Financials Status: current
Financials Updated: 2026-05-18T23:01:46.001Z
Financials Last Attempt: 2026-05-18T23:01:46.001Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹109.66 Cr
Operating Profit: ₹-9.83 Cr (OPM -8.96%)
Net Profit: ₹0.85 Cr
Tax: ₹0.5 Cr

## Annual P&L History
FY25: Rev ₹109.66Cr | PAT ₹0.85Cr | OPM -8.96%
FY24: Rev ₹91.93Cr | PAT ₹-1.79Cr | OPM -13.67%
FY23: Rev ₹111.32Cr | PAT ₹-8.25Cr | OPM -15.4%

## Balance Sheet (FY25)
Total Assets: ₹209.98 Cr
Total Liabilities: ₹15.69 Cr
Borrowings: ₹4.97 Cr
Cash: ₹3.24 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Saurabh  Goyal, Co-Founder, MD & Chairman
- Aryan  Goyal, Co-Founder, CEO & Whole-time Director
- Rajinder  Sharma, Whole-Time Director
- Gurvikram  Singh, Assistant Manager of Investors Relations & Corporate Affairs
- Nishu  Kansal, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/nureca
Disclaimer: For research and education only. Not investment advice.